Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Adult Subjects with Classic Congenital Adrenal Hyperplasia
Sponsored by Spruce Biosciences, Inc.
Active
$56.4K Funding
4 People
External
Related Topics
adrenal hyperplasia,
clinical trial,
drug efficacy,
safety evaluation,
dose-ranging
People
Nikki Marshell
(CD)
College of Medicine - Phoenix
﹒Clinical Research Coordinator IV
Elena Young
(CD)
College of Medicine - Phoenix
﹒Research Compliance Manager II
Janette Priefert
(CD)
College of Medicine - Phoenix
﹒Computing Sciences Researcher III
Mason Burchfield
(CD)
College of Medicine - Phoenix
﹒Research Compliance Administrator III
